Digital Diabetes Management Market Size, Share & Trends Analysis Report By Product (Smart Glucose Meter, CBGM, Smart Insulin Pen, Smart Insulin Pump), By App, By Type, And Segment Forecasts, 2019 - 2026

Report Overview

The global digital diabetes management market size valued at USD 6.3 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 19.4% from 2019 to 2026. Robust growth of the market is majorly attributed to increasing technological advancements and innovations in the field. The number of smartphones apps available for disease management has increased over the last few years and there are several apps available on web-based app stores that can help patients monitor their blood glucose levels.

Key factors driving the market include growing geriatric population, increasing disease incidence, and rising healthcare spending. According to the International Diabetes Federation, approximately 425 million adults were living with diabetes in 2017 and this number is expected to reach 629 million in 2045. As digital technology is continuously advancing, the market is expected to witness a wide range of innovations in the field of diabetes, which could have the potential to change the way patients manage this disease.

Rapidly changing lifestyles and unhealthy dietary habits are contributing to the rise in prevalence of diabetes worldwide. Obesity is also one of the major factors contributing to diabetes. According to WHO, more than 650 million people were obese in 2016 and this number is expected to grow further during the forecast period. The market for diet and weight management apps is showing great potential with increasing obese population, coupled with increasing awareness about the same.

Diabetes is a clinical condition wherein the inability of the pancreas to produce insulin causes increased glucose levels in the body. Diabetics face many daily challenges such as dietary restrictions and regular administering of insulin. The anytime-anywhere nature of digital technology enables patients to address their health issues by connecting with the healthcare team and sharing data. This is creating a digital ecosystem of data driven tools that can connect patients and their care team for better management of diabetes.

Digital Diabetes Management Market Trends

Robust growth in AI can enable access to unstructured health data as well as real-time structured data available for doctors & patients. AI can help harness large volumes of data to help meet patient demands. A survey found that 68% of mobile health app publishers believe that diabetes remains the single most important area in healthcare, and it has the best market potential for digital health solutions. Several startups are transforming the digital diabetes management market.

Diabetes patients are now using smart devices that can provide real-time blood glucose readings and help patients take immediate decisions. Patients are using AI-based apps for monitoring their daily diet and insulin requirements. Several government initiatives and the launch of learning platforms for diabetes patients around the world are likely to further propel the market.

The advent of noninvasive devices is likely to induce high growth rate in the digital diabetes management market. The smart insulin pump market is expected to grow during the forecast period. The market is at an intermediate phase and many new players are innovating their products. The market is expected to see high growth rate due to increasing number of FDA approvals and rapid technological advancements. Insulin pumps eliminate the possibility of guesswork by making necessary calculations to assist with insulin dosage, which is a high impact-rendering factor to market growth.

High cost of devices is one of the keys restraints of the market. The significant increase in the number of diabetic patients, especially those who require daily insulin dosage, is creating a major surge in the demand for diabetes care products. The global financial burden related to diabetes is expected to reach USD 2.5 trillion per year by 2030.

The high cost of diabetes in low- and middle-income countries can cause a substantial economic burden for individuals, households, and health systems. Studies in India estimated that, for a low-income Indian family with an adult suffering from diabetes, an estimated 20% of the family’s income goes into diabetes care. There is also the indirect cost involved, which results from lost production as a result of frequent absence from work.

Product Insights

Based on product, the market has been segmented into smart glucose meter, continuous blood glucose monitoring systems, smart insulin pens, smart insulin pumps, and apps. Continuous blood glucose monitoring systems held the largest market share of just under 40.0% in 2018 owing to their compatibility with smart devices that serve as a display device. Moreover, they can also be set to send custom alerts to patients when certain glucose thresholds are reached.

The smart insulin pen segment is expected to grow at the highest CAGR of 22.0% over the forecast period. The high growth rate of the segment is majorly attributed to increasing number of product launches in the field of digital healthcare and introduction of artificial intelligence. Many market players are focusing on innovating smart insulin pen to stay ahead of the competition. For instance, Companion Medical’s InPen system, which was launched in December 2017, is the first FDA-approved solution that can connect with smartphone apps.

App Insights

By apps, the market is divided into digital diabetes management apps and apps for weight and diet management. The former segment captured the largest market share in 2018 and was valued at USD 173.0 million that year. The growth of the segment is majorly attributed to increasing preference of patients for these apps. Such apps allow continuous monitoring of blood glucose levels and are widely used by the elderly population as well.

The weight and diet management apps segment also holds a considerable share in the market owing to increasing awareness of chronic diseases such as diabetes and its related complications. These apps use advanced digital data analytics to allow healthcare professionals to provide patients with the best possible solution. Key factors driving this segment are improved health outcomes, reduction of error rates, and declining healthcare costs. This segment is expected to register a CAGR of 22.0% over the forecast period.

Type Insights

Based on type, the digital diabetes management market has been segmented into wearable and handheld devices. Wearable devices held the largest market share and the segment is expected to exhibit the fastest CAGR of 19.6% over the forecast period. The growth of the market is majorly attributed to technological advancements such as advent of artificial intelligence, growing adoption self-administering insulin delivery devices in diabetes management, and launch of new products such as closed-loop pump systems and smart insulin patches.

The handheld device segment accounted for a share of over 43.0% in 2018 and poised to witness stead growth over the forecast period. This is primarily attributed to new product launches in the field. For instance, in June 2018, Insulet Corporation received FDA approval for its handheld dash system. The device is a touchscreen personal diabetes manager with Wi-Fi connectivity that allows the software to be remotely updated.

Regional Insights

Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. North America dominated the market in 2018 driven by increasing penetration of smart consumer devices and innovation in AI-based services. Furthermore, the region is in the next stage of digitization of concepts such Internet of Things, big data, machine learning, and robotics. Thus, these digital technologies are expected to propel the regional market during the forecast period. Europe is also expected to capture a considerable share over the forecast period owing to novel product launches and presence of key players in the region.

Key market drivers in the Canadian market are growth in R&D efforts undertaken in the field of digital diabetes and imminent product launches. In February 2019, Dexcom G6 CGM System received Health Canada’s approval for sales. In October 2018, Tandem Diabetes Care, Inc, received Health Canada’s Medical Devices Approval for its t: slim x2 insulin pump. This was the only Insulin pump that can connect with the Dexcom G5 Mobile CGM.

Increasing incidence of diabetes and growing geriatric population are expected to contribute to the growth of Italian market over the forecast period. Currently, over 3 million people are suffering from diabetes in Italy. According to the International Diabetes Federation, this number is expected to increase to approximately 5 million by 2030. The National Diabetes Program helps raise awareness and improve the quality & accessibility of diabetes care available to patients.

Asia Pacific is expected to witness exponential growth over the forecast period owing to new product launches and a large diabetes population base. Currently, over 230 million people are living with diabetes, accounting for approximately 55.0% of the global population. The region is also witnessing many product launches. For instance, in May 2019, Roche Diabetes Care India introduced its Integrated Diabetes Management Solution (IDMS) program in India with the launch of Accu-Chek Instant blood glucose monitoring (BGM) system and the My Sugar app. The combination marks the entry of next-generation BGM systems

Key Companies & Market Share Insights

Some of the prominent players are Abbott Laboratories; Medtronic plc; F. Hoffmann-La Roche Ltd; Bayer AG; Lifescan, Inc.; Dexcom, Inc.; Sanofi; Insulet Corporation; Ascensia Diabetes Care Holdings Ag; and B Braun Melsungen AG. These players are focused on adopting new technologies and introducing advanced products in order to offer better services to their customers and to strengthen their presence in the market. For instance, in June 2018, Medtronic Plc, along with its technology partner IBM Watson Health, launched the Sugar. IQ smart diabetes assistant. This intelligent app is designed to improve daily diabetes management. Some of the prominent players in the digital diabetes management market include:

• Abbott Laboratories

• Medtronic plc

• F. Hoffmann-La Roche Ltd

• Bayer AG

• Lifescan, Inc.

• Dexcom, Inc.

• Sanofi

• Insulet Corporation

• Ascensia Diabetes Care Holdings Ag

• B Braun Melsungen AG 

Digital Diabetes Management Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels as well as provides an analysis on the latest industry trends in each of the sub-segments from 2015 to 2026. For the purpose of this study, Grand View Research has segmented the global digital diabetes management market report on the basis of product, type, app, and region:

• Product Outlook (Revenue, USD Million, 2015 - 2026)

  • Smart glucose meter

  • Continuous blood glucose monitoring system

  • Smart insulin pens

  • Smart insulin pumps

  • Apps

• App Outlook (Revenue, USD Million, 2015 - 2026)

  • Digital diabetes management apps

  • Weight & diet management apps

• Type Outlook (Revenue, USD Million, 2015 - 2026)

  • Wearable devices

  • Handheld devices

• Regional Outlook (Revenue, USD Million, 2015 - 2026)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • The U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE